The transcranial magnetic stimulator (TMS) market is projected to reach US$ 2,029.71 million by 2028 from US$ 1,122.22 million in 2021; it is expected to register a CAGR of 8.8% from 2021 to 2028.
Neurological disorders affect the brain and nerves of the human body and cause epilepsy and seizures, Parkinson’s disease, dementia, autism, Alzheimer’s disease, brain tumors, and cerebral palsy, among others.The prevalence of neurological disorders is increasing across the world.
According to the Global Burden of Disease Study (GBD) 2017, Alzheimer’s disease and other dementias [2.55 million Disability Adjusted Life Years (DALYs)], stroke (about 3.58 million DALYs), and migraine (about 2.40 million DALYs) were the three most burdensome neurological diseases in the US in terms of a total number of disability-adjusted life. Further, the Alzheimer’s Association estimates that over 6 million Americans have Alzheimer’s disease, and the number is projected to reach nearly 13 million by 2050.TMS is widely used for the diagnosis and treatment of neurological disorders.
For instance, according to BrainsWay Ltd., in April 2021, 100,000 patients across the world were treated with its Deep TMS. Thus, the growing prevalence of neurological disorders drives the growth of the transcranial magnetic stimulator (TMS) market globally. Moreover, depression is one of the mental disorders observed commonly among people worldwide. As per the data published by WHO in January 2020, more than 264 million people of all ages suffer from depression across the world. The global transcranial magnetic stimulator (TMS) market is segmented based on type, age group, and application. Based on type, the market is segmented into single or paired pulse TMS and repetitive TMS (rTMS). in 2021, the single or paired pulse TMS segment held a larger share of the market, by type. The repetitive TMS (rTMS) segment is expected to witness a higher CAGR during 2021–2028. Based on age group, the market is segmented into adults and children. In 2021, the adults segment held a larger share of the market and is expected to grow at a higher CAGR during the coming years. Based on application, the market is segmented into research, diagnostic, and therapeutic. In 2021, the diagnostic segment held the largest share of the market and is expected to grow at the highest CAGR during the coming years. The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and National Health and Wellness are among the primary and secondary sources referred to while preparing the report on the transcranial magnetic stimulator (TMS) market. .
Our reports have been used by over 10K customers, including:
The global companion diagnostics market is projected to reach USD 9.9 billion by 2026 from USD 5.5 billion in 2021, at a CAGR of 12.6% during the forecast period. Market growth is driven by factors such as the growing significance of companion diagnostics in drug development and rising incidence of cancer and growing adoption of targeted therapies. "The...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Labware Market Report The development of the laboratory glassware market is linked with the growth of industries like petrochemicals, polymer chemistry, and pharmaceuticals. Numerous manufacturers of laboratory glassware majorly rely on exports...
212 pages •
By Asia Market Information & Development Company
• Feb 2022
China’s demand for Patient Monitoring and Diagnostic Systems has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import...
The Liver cancer diagnostics market size is projected to reach US$ US$ 15,951.77 million by 2028 from US$ 9,323.14 million in 2021; it is estimated to grow at a CAGR of 8.0% during 2021–2028. The report highlights the key factors driving the market and prominent players with their developments.The growth of the liver cancer diagnostics...
The infectious disease diagnostics market is expected to grow from US$ 23,890 million in 2021 to US$ 37,943.90 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving the infectious disease diagnostics market growth. The market growth is attributed...
237 pages •
By Asia Market Information & Development Company
• Apr 2022
China’s demand for Diagnostic Medical Equipment has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...
The global drug of abuse testing market is predicted to reach US$ 6.6 Billion by 2027. The use of illicit drugs is increasing across the globe. According to the UN Office on Drugs and Crime (UNODC) World Drug Report 2021, about 5.5 percent of the population aged between 15 and 64 years have used drugs at least once in the past year, while...
The human microbiome market is projected to reach USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development &...
The concussion market is expected to growth from US$ 7,211.89 million in 2021 to US$ 9,272.03 million by 2028. It is estimated to grow at a CAGR of 3.7% during 2021–2028. According to the Centers for Disease Control and Prevention (CDC) a concussion is a type of traumatic brain injury-or TBI caused by a bump, blow, or jolt to the head...
The molecular quality controls market size is expected to grow from USD 164 million in 2021 to USD 226 million by 2026, at a CAGR of 6.7% during the forecast period. The growth of this market is primarily driven by factors such as the rising adoption of third-party quality controls, increasing number of accredited clinical laboratories, the...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.